Aster Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Aster Capital Management's AMPH Position: Q3 2026 in Review
Aster Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2026, closing a stake of 238 shares — an estimated $4.8K sold.
Aster Capital Management first reported a position in AMPH in Q4 2024 and held it in 3 quarters. The position peaked at $107K in Q4 2024. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Aster Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Aster Capital Management sold 238 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $4.8K.
- Aster Capital Management first reported a position in Amphastar Pharmaceuticals in Q4 2024 and held it in 3 quarters.
- Aster Capital Management's Amphastar Pharmaceuticals position peaked at $107K in Q4 2024.
- 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.